Amal El Daibani

425 total citations
9 papers, 174 citations indexed

About

Amal El Daibani is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Amal El Daibani has authored 9 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 2 papers in Physiology. Recurrent topics in Amal El Daibani's work include Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Amal El Daibani is often cited by papers focused on Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (7 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Amal El Daibani collaborates with scholars based in United States, Denmark and China. Amal El Daibani's co-authors include Tao Che, Petr Popov, Kuglae Kim, Joseph M. Paggi, B. Krumm, F. Ivy Carroll, Reid H. J. Olsen, Jeffrey F. DiBerto, Vsevolod Katritch and Sarah M. Bernhard and has published in prestigious journals such as Nature, Nature Communications and Biochemistry.

In The Last Decade

Amal El Daibani

9 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amal El Daibani United States 7 123 72 23 19 19 9 174
Carlos Luna‐Tortós Germany 6 60 0.5× 65 0.9× 8 0.3× 36 1.9× 14 0.7× 6 569
Brian Boucher United States 5 166 1.3× 26 0.4× 27 1.2× 13 0.7× 6 0.3× 5 369
Lorenza Bellusci United States 9 107 0.9× 45 0.6× 6 0.3× 4 0.2× 36 1.9× 22 278
Shawn M. Lamothe Canada 12 257 2.1× 90 1.3× 4 0.2× 12 0.6× 32 1.7× 28 374
Alexandra E. Conibear United Kingdom 6 288 2.3× 260 3.6× 11 0.5× 24 1.3× 73 3.8× 8 394
Pia K. Nørregaard Denmark 9 175 1.4× 124 1.7× 10 0.4× 13 0.7× 69 3.6× 12 383
Katie A. McCrink United States 10 207 1.7× 74 1.0× 7 0.3× 19 1.0× 18 0.9× 22 328
Bo‐Wei Wu China 12 216 1.8× 59 0.8× 26 1.1× 6 0.3× 18 0.9× 36 332
Eugenia Sergeev United Kingdom 8 227 1.8× 97 1.3× 6 0.3× 4 0.2× 66 3.5× 13 304
Alexander Gillis Australia 5 278 2.3× 273 3.8× 14 0.6× 16 0.8× 46 2.4× 7 358

Countries citing papers authored by Amal El Daibani

Since Specialization
Citations

This map shows the geographic impact of Amal El Daibani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal El Daibani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal El Daibani more than expected).

Fields of papers citing papers by Amal El Daibani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal El Daibani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal El Daibani. The network helps show where Amal El Daibani may publish in the future.

Co-authorship network of co-authors of Amal El Daibani

This figure shows the co-authorship network connecting the top 25 collaborators of Amal El Daibani. A scholar is included among the top collaborators of Amal El Daibani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal El Daibani. Amal El Daibani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Daibani, Amal El, et al.. (2025). Delta opioid receptors: Overlooked outlier or the next big thing. Current Opinion in Pharmacology. 83. 102528–102528. 1 indexed citations
2.
O’Brien, Evan S., Amal El Daibani, Shainnel O. Eans, et al.. (2024). A µ-opioid receptor modulator that works cooperatively with naloxone. Nature. 631(8021). 686–693. 18 indexed citations
3.
Lu, Dongliang, Anyuan He, Min Tan, et al.. (2024). Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling. Nature Communications. 15(1). 4214–4214. 36 indexed citations
4.
O’Brien, Evan S., Amal El Daibani, Shainnel O. Eans, et al.. (2024). Negative allosteric modulation of the µ-opioid receptor. Biophysical Journal. 123(3). 353a–353a. 1 indexed citations
5.
Daibani, Amal El, et al.. (2023). Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells. JACS Au. 3(4). 1076–1088. 17 indexed citations
6.
Daibani, Amal El, Joseph M. Paggi, Kuglae Kim, et al.. (2023). Molecular mechanism of biased signaling at the kappa opioid receptor. Nature Communications. 14(1). 1338–1338. 56 indexed citations
7.
Daibani, Amal El & Tao Che. (2022). Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain. Molecules. 27(3). 595–595. 19 indexed citations
8.
Daibani, Amal El & Tao Che. (2021). Nanobodies as sensors of GPCR activation and signaling. Methods in cell biology. 166. 161–177. 6 indexed citations
9.
Zhou, Yuchen, Steven Ramsey, Davide Provasi, et al.. (2020). Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom’s Alkaloids with Reported Antinociception In Vivo. Biochemistry. 60(18). 1420–1429. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026